Results 161 to 170 of about 101,002 (279)
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. [PDF]
Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous and complex disease that is imprecisely diagnosed by liver biopsy. NAFLD covers a spectrum that ranges from simple steatosis, nonalcoholic steatohepatitis (NASH) with varying degrees of fibrosis,
Alonso, Cristina +3 more
core
Guidance for Liver Rehabilitation in Chronic Liver Disease
ABSTRACT In April 2023, the Japan Society of Hepatology published its official guidelines on liver rehabilitation for chronic liver disease. In this article, we summarize the current evidence on the role of liver rehabilitation in slowing the progression of chronic liver disease, particularly metabolic dysfunction‐associated steatotic liver disease ...
Shuji Terai +26 more
wiley +1 more source
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is quickly emerging as a global public health concern, primarily fueled by the rising consumption of processed and ultraprocessed foods. This global health issue, showing a 50% increase in prevalence over two decades to 38% of the global population, is now the second most common ...
Arunkumar Krishnan +9 more
wiley +1 more source
ABSTRACT In a scenario with increasing cases of obesity and diabetes worldwide, branched‐chain amino acids (BCAA) metabolism has become an important factor in the understanding of these pathologies. More recently, its chronic high plasma levels have been postulated, alongside glucose, inflammatory factors, and other molecules, as an important ...
Bernardo Starling‐Soares +4 more
wiley +1 more source
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized condition whose symptoms and pathology resemble those of alcohol-induced liver injury. NAFLD includes fatty liver, steatohepatitis (NASH) with inflammatory changes and fibrosis, and cirrhosis.
Rodés i Teixidor, Joan +1 more
openaire +3 more sources
Nonalcoholic Fatty Liver Disease: Evidence-Based Management and Early Recognition of Nonalcoholic Steatohepatitis [PDF]
Nicole Kelly, Julia Wattacheril
openalex +1 more source
Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes [PDF]
Kenneth Cusi
openalex +1 more source
ABSTRACT Obesity as a chronic and multifactorial disease requires a multidisciplinary team acting together in a holistic multitarget intervention. Multidisciplinary therapy targeting obesity and its complications includes physical exercise, nutritional, and behavior counseling.
Ana Raimunda Dâmaso +7 more
wiley +1 more source
Limited role for hyperammonemia in the progression of diet‐induced nonalcoholic steatohepatitis [PDF]
Zi Xuan Wang +6 more
openalex +1 more source

